AstraZeneca resumed clinical trials for its investigational COVID-19 vaccine Saturday, after briefly pausing the trial globally to investigate reports of a potential severe adverse in a patient in the United Kingdom. In a brief press release, AstraZeneca announced that Phase 3 trials for the vaccine, AZD1222, have resumed in the UK on 12 September following […] Continue reading ->
The chief executive officers of nine biopharmaceutical companies at the forefront of the COVID-19 vaccine development race have signed a pledge to fully test the safety and efficacy of an investigational vaccine before rolling it out for mass use. The top executives of AstraZeneca, BioNTech, GlaxoKlineSmith, Johnson&Johnson, Merck, Moderna, Novavax, Sanofi, and Pfizer signed the […] Continue reading ->
A new US $200 million program, financed by the United States Agency for International Development (USAID), aims to strengthen health data systems in developing countries. USAID is currently developing the scope of this project, including country participation, according to a spokesperson from global health NGO and partner on the project, Vital Strategies. Strengthening health information systems […] Continue reading ->
The World Health Organization recommended postponing routine dental visits in areas with community transmission of COVID-19 in new guidelines released last week.  Many dental procedures can generate aerosols, or tiny solid or liquid particles that contain disease-causing pathogens. If dentists were unknowningly treating coronavirus infected patients, aerosols laden with SARS-CoV-2, the virus that causes COVID-19, […] Continue reading ->
Funding for research into sexual and reproductive health issues, ranging from HIV/AIDs to pregnancy prevention, comes from only three major donors, and the global recession caused by COVID-19 may shrink the funding landscape further. “There’s a clear gap in investment to research and develop new products to meet people’s needs in low-resource settings. With a […] Continue reading ->
The racing sport Formula 1 (F1) has made more than US $4.4 billion in advertising and sponsorship from tobacco companies in the past seven decades, according to a report published by F1 industry monitor Formula Money and global tobacco industry watchdog STOP. The first-ever analysis of its kind, Driving Addiction: F1 and Tobacco Advertising, was published just […] Continue reading ->